Effects of integrelin on platelet function in flow models of arterial thrombosis

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 2, 1997, Pages 156-163

  Kamat, Suraj G ^a   Turner, Nancy A ^b   Konstantopoulos, Konstantinos ^b   Hellums, J David ^b   McIntire, Larry V ^b   Kleiman, Neal S ^a   Moake, Joel L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RICE UNIVERSITY   (United States)

Author keywords

Flow c7E3; Integrelin; Platelet aggregation; Shear

Indexed keywords

COLLAGEN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; PLACEBO; SODIUM CHLORIDE; VON WILLEBRAND FACTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

NON-PROGRAMMATIC;

BLOOD PLATELETS; HUMANS; PEPTIDES; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 0031036920     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199702000-00002     Document Type: Article

References (29)

1. Sixma J, Nievelstein P, Houdijk W, van Breugel H, Hindriks H, de Groot P. Adhesion of blood platelets to isolated components of the vessel wall. Ann N Y Acad Sci 1987;509:103-17.
2. Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium. Nature 1979;279: 636-8.
3. Houdijk P, Sakariassen KS, Nievelstein PFEM, Sixma JJ. Role of factor VIII-von Willebrand factor and fibrinectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest 1985;75:531-40.
4. Turitto VT. Blood viscosity, mass transport, and thrombogenesis. Prog Hemost Thromb 1982;6:139-77.
5. Back CH, Radbill JR, Crawford DW. Analysis of pulsatile viscous blood flow through diseased coronary arteries of man. J Biomech 1977;10:339-53.
6. Lipowski HH, Usami S, Chien S. In vivo measurements of "apparent viscosity" and microvessel hematocrit in the mesentery of the cat. Microvasc Res 1980;19:297-319.
7. Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 1992;80: 113-20.
8. Ikeda Y, Handa M, Kamata T, et al. Transmembrane calcium influx associated with von Willebrand factor binding to GPIb in the initiation of shear-induced platelet aggregation. Thromb Haemost 1993;69:496-502.
9. Alevriadou BR, Moake JL, Ruggeri ZM, et al. Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor to binding to platelets. Blood 1993;81:1263-76.
10. Turner NA, Moake JL, Kamat SG, et al. Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin and monoclonal fragment against glycoprotein IIb-IIIa. Circulation 1995;91:1354-62.
11. Ellis S, Roubin G, Wilentz J. Results of a randomized trial of heparin and aspirin vs aspirin alone for prevention of acute closure and restenosis after PTCA [Abstract]. Circulation 1987;213.
12. Moake JL, Turner NA, Stathopoulos NA, Nolasco LH, Hellums JD. Shear-induced platelet aggregation can be mediated by vWf released from platelets, as well as by exogenous large or unusually large vWf multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 1988;71:1366-74.
13. Ellis S, Roubin G, Wilentz J. Effect of 18-24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989;117:777-82.
14. E.P.I.C. Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
15. Konstantopoulos K, Kamat SG, Shafer AI, et al. Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty. Circulation 1995;91:1427-31.
16. Tcheng JE, Harrington RA, Kottke-Marchant K, et al. Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. Circulation 1995;91:2151-7.
17. Scarborough RM, Naughton MA, Teng W, et al. Design of potent and specific integrin antagonists: peptide antagonists with high specificity for glycoprotein IIb-IIIa. J Biol Chem 1993;268:1066-73.
18. Bergman I, Loxley R. Two improved and simplified methods for the spectrophometric determination of hydroxyproline. Anal Chem 1963;35:1961.
19. Folie BJ, Mclntire LV, Lasslo A. Effects of a novel antiplatelet agent in mural thrombogenesis on collagen-coated glass. Blood 1988;72: 1393-400.
20. Hubbell JA, Mclntire LV. Technique for visualization and analysis of mural thrombogenesis. Rev Sci Instrum 1986;57:892-7.
21. Hubbell JA, Mclntire LV. Visualization and analysis of mural thrombogenesis on collagen, polyurethane and nylon. Biomaterials 1986;7:354-63.
22. Dise CA, Bursh JW, Goodman DBD. Direct interaction of mepacrine with erythrocyte and platelet membrane phospholipid. J Biol Chem 1982;257:4701-4.
23. Goldsmith HL, Turritto VT. Rheological aspects of thrombosis and haemostasis: basic principles and application. Thromb Haemost 1986;55:415-35.
24. Russ JC. Computer-assisted microscopy. In: The measurement and analysis of images. New York: Plenum, 1990:33-220.
25. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983;61:99-110.
26. Konstantopoulos K, Wu KK, Udden MM, Bañez EI, Shattil SJ, Hellums JD. Flow cytometric studies of platelet responses to shear stress in whole blood. Biorheology 1995;32:73-93.
27. Goding JW In: Monoclonal antibodies: principles and practice. New York: Academic Press, 1983:208-49.
28. Rochon YP, Frojmovic MM. Dynamics of human neutrophil aggregation evaluated by flow cytometry. J Leukoc Biol. 1991;50: 434-43.
29. Zar JH. Biostatistical analysis. NJ: Prentice-Hall, 1984.